Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003468432 | SCV004214265 | likely pathogenic | Aspartylglucosaminuria | 2023-01-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003468432 | SCV004292775 | pathogenic | Aspartylglucosaminuria | 2023-02-14 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg66Serfs*7) in the AGA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AGA are known to be pathogenic (PMID: 7627186, 11309371). This variant is present in population databases (rs779157725, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with AGA-related conditions. For these reasons, this variant has been classified as Pathogenic. |